← Open Payments lookup

BRUCE CHRISTENSEN: Open Payments

NPI 1770616054 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$581 in 25 payments from 14 companies in 2025. Trend: 2023 $280 · 2024 $240 · 2025 $581

Food & beverage: $581
CompanyPaymentsAmount
Janssen Biotech, Inc.4$100
AstraZeneca Pharmaceuticals LP4$98
Takeda Pharmaceuticals U.S.A., Inc.3$69
Genentech USA, Inc.2$54
ABBVIE INC.2$51
JAZZ PHARMACEUTICALS INC.2$46
TerSera Therapeutics LLC1$28
Celgene Corporation1$23
CSL Behring1$23
Melinta Therapeutics, LLC1$21

Products named: RYBREVANT, LYNPARZA, ZEPZELCA, HYQVIA, DARZALEX, VONVENDI, Polivy, VENCLEXTA.

Industry payments across TX — which companies pay providers there.